期刊文献+

165例骨转移癌的临床分析 被引量:3

Clinical Analysis of 165 Cases with Metastatic Carcinoma of Bone
下载PDF
导出
摘要 目的:探讨骨转移癌患者的临床特点及止痛效果,提高诊断及治疗水平。方法:回顾性分析165例骨转移癌患者的临床资料观察近期疗效。结果:165例骨转移癌患者的发病年龄为20岁~90岁,中位年龄58岁,男女比值为1.5:1,族别以汉族及维吾尔族居多,汉族患者出现转移部位的疼痛比率低于维族患者,P<0.05,差异有统计学意义。近半数(44.24%)在确诊原发灶及治疗前已有骨转移。肺癌出现骨转移的时间最早,中位时间6月,原发灶较多的有:肺癌(34.54%)、前列腺癌(10.9%)、乳腺癌(9.7%)、宫颈癌(7.27%)、肝癌(6.67%)。全身多发转移占74.54%。转移部位以脊柱、骨盆、肋骨等部位多见,分别占80.6%、26.06%、19.39%,其中89.7%的患者有骨痛症状,少数表现为脊髓压迫、截瘫、病理性骨折。经过多因素分析发现,治疗方式是止痛效果的影响因素,联合治疗较其他治疗方式相比,P<0.05,有统计学意义。结论:165例骨转移癌患者中以汉族及维族多见,且宫颈癌在原发灶中占有较大的比例,汉族患者对疼痛的耐受性较维族患者好,骨转移癌影响患者生活质量,联合治疗方式的止痛效果好,改善患者生活质量。 Objective:To analyze the epidemiologic and clinical features of metastatic bone tumor.Methods: 165 cases with clinical diagnosis of metastatic bone admitted from several aspects.Results;Men were 1.5 times more commonly affected than women.It occurred frequently at the age 20~90,the median age is 58.The individual nationality,with the majority Han and Uygur,Han patients with ratio is lower than the Uygur,P 0.05.Nearly half(44.24%) of them had have bone metastases before the primary tumor was diagnosis and treatment.The top five common metastases were lung cancer(34.54%),prostate cancer(10.9%),breast cancer(9.7%),cervical cancer(7.27%),liver cancer(6.67%).Systemic multiple metastases accounted for 74.54%.The spine,pelvis and rib were the most common metastatic sites.The main symptom was pain(89.7%).after multivariate analysis, treatment effect is the pain factor,combination therapy compared with other forms of treatment,P 0.05.Conclusion: In 165 cases of metastatic bone cancer patients;the Han and Uygur were common in bone metastases cancer. The study indicates that cervical cancer was account for a proportion of patients in the primary tumors.Han patients with pain tolerance were better than Uygur.Bone metastases affect the quality of life,combination therapy of pain was better.
出处 《新疆医学》 2012年第11期19-23,共5页 Xinjiang Medical Journal
关键词 骨转移癌 临床特点 止痛效果 bone metastasis clinical features effect relieve pain
  • 相关文献

参考文献21

  • 1T sukush iS, KatagiriH, K ataoka T, et al, Serum tumor markers in skeletal metastasis [ J]. Jpn J Clin Onco,1 2006 ;36(7) :g39144].
  • 2Nguyen DX, M assagu J'. Gen et ic determinants of cancer metastasis [J]. Nat Rev Genet, 2007 ;8 (5) : 341- 52.
  • 3A. G. Horvat, V. Kovav c, and P. Strojan, "Ra- diotherapy in palliative treatment of painful bone metastases," Radiology and Oncology, 2009 ; 43 (4), 213-224.
  • 4Salmon J, Kilpatrick S Pathology of skeletal metas- tases[J] Ortho p Clin North Am, 2000;31 (4) : 537 [44 ].
  • 5Paice JA, FerreU B, The Mtmagement of Cancer Pain. CA Cancer[J] Clin, 2011 ;61 : 157 - 182.
  • 6上海市肿瘤研究所流行病学研究室.2000年上海市恶性肿瘤发病率[J].肿瘤,2003,23:532-532.
  • 7Y oneda T, cercells and H i raga T bone micro tastasis [ J ] . B 2005 ;32(8) :679 Crosstal k between can environment in bone me- iochem Biophys Res Commun, - 687.
  • 8Suresh M, Katherine NW, Michael LC. Third North American symposium on skeletal co replica- tions, of malignancy [ J ]. Cancer , 2003 ; 97 ( 3 ) : 719 -725.
  • 9陈晓钟,张鸿未.骨转移瘤的临床研究进展[J].中国肿瘤,2006,15(3):183-186. 被引量:44
  • 10J kman DM, Johnson BE. Small cell 'lung cancer[J]. Lancet,2005;366(9494) : 1385.

二级参考文献60

共引文献171

同被引文献29

引证文献3

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部